CMV INFECTION
Clinical trials for CMV INFECTION explained in plain language.
Never miss a new study
Get alerted when new CMV INFECTION trials appear
Sign up with your email to follow new studies for CMV INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Donor cells take on Drug-Resistant viruses in new trial
Disease control Recruiting nowThis early-phase trial tests a treatment called LB-DTK-MV, which uses immune cells from a healthy donor to fight three viruses (CMV, BKV, and EBV) that have become resistant to standard antiviral drugs. The study includes 27 adults who have had a stem cell transplant or certain c…
Matched conditions: CMV INFECTION
Phase: PHASE1, PHASE2 • Sponsor: LucasBio • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Supercharged immune cells take on Drug-Resistant infections
Disease control Recruiting nowThis trial investigates whether specially grown immune cells, called pathogen-specific cytotoxic T lymphocytes (CTLs), can safely and effectively treat stubborn infections like EBV, CMV, and adenovirus in people with weakened immune systems, such as stem cell or organ transplant …
Matched conditions: CMV INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Malaria drug could help fight dangerous virus in transplant patients
Disease control Recruiting nowThis study tests whether adding the malaria drug artesunate to standard antiviral treatment can better control cytomegalovirus (CMV) infection in people who have received a solid organ transplant (kidney, lung, heart, or liver). About 90 adult participants will receive either a l…
Matched conditions: CMV INFECTION
Phase: PHASE2 • Sponsor: Amivas Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC